ID: ALA5281064

Max Phase: Preclinical

Molecular Formula: C9H4ClFO2S

Molecular Weight: 230.65

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1sc2cc(F)ccc2c1Cl

Standard InChI:  InChI=1S/C9H4ClFO2S/c10-7-5-2-1-4(11)3-6(5)14-8(7)9(12)13/h1-3H,(H,12,13)

Standard InChI Key:  HSRSWUJIPYUCSE-UHFFFAOYSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 230.65Molecular Weight (Monoisotopic): 229.9605AlogP: 3.39#Rotatable Bonds: 1
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.21CX Basic pKa: CX LogP: 3.39CX LogD: -0.06
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.82Np Likeness Score: -1.97

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source